Maxime FIEUX
Equipe : Vecteurs colloïdaux et ingénierie thérapeutique ciblée
Courriel : maxime.fieux@chu-lyon.fr
Téléphone : +33(0)4-72-72-26-62
Statut :
6 publications au total. Seules les 5 dernières années sont affichées
2024
6. Vestibular Assessment with the vHIT and Skull Vibration-Induced Nystagmus Test in Patients with Nonprogressive Vestibular Schwannoma.
Brudasca I, Vassard-yu G, Fieux M, Tournegros R, Dumas O, Dumas G, Tringali S
(2024) J Clin Med 13 :
5. Artificial Intelligence for Otosclerosis Detection: A Pilot Study.
Emin A, Daubié S, Gaillandre L, Aouad A, Pialat Jb, Favier V, Carsuzaa F, Tringali S, Fieux M
(2024) J Imaging Inform Med 37 :2931-2939
4. Dupilumab prevents nasal epithelial function alteration by IL-4 in vitro: Evidence for its efficacy.
Fieux M, Carsuzaa F, Bellanger Y, Bartier S, Fournier V, Lecron Jc, Bainaud M, Louis B, Tringali S, Dufour X, Coste A, Favot L, Bequignon E
(2024) Int Forum Allergy Rhinol 14 :1337-1349
3. Internal Nasal Valve Collapse Treatment by Endonasal Hyaluronic Acid Injection.
Gagnieur P, Fieux M, Saloner L, Louis B, Vertu-ciolino D, Mojallal Aa
(2024) Aesthetic Plast Surg :
2023
2. In vivo intranasal delivery of coagulation factor IX: a proof-of-concept study.
Fieux M, Rovera R, Coiffier C, Colomb E, Enjolras N, Béquignon E, Monge C, Le Quellec S
(2023) J Thromb Haemost :
1. Persistent retro-orbital pain after acute otitis media.
Tournegros R, Tringali S, Fieux M
(2023) Eur Ann Otorhinolaryngol Head Neck Dis 140 :247-249
